Lowenstein Sandler represented issuer Celldex Therapeutics, Inc. in the offering. Celldex Therapeutics, Inc. (Celldex) (Nasdaq: CLDX) completed a $150 million public offering of common stock underwritten…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
